Can I use Flonase (fluticasone nasal spray) together with Augmentin (amoxicillin‑clavulanate) to treat bacterial sinusitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, use both Flonase (fluticasone nasal spray) and Augmentin (amoxicillin-clavulanate) together for bacterial sinusitis.

Combining intranasal corticosteroids like Flonase with Augmentin is recommended as adjunctive therapy for acute bacterial rhinosinusitis (ABRS), particularly in patients with allergic rhinitis, and provides faster symptom relief than antibiotics alone. 1

The Evidence-Based Approach

Antibiotic Selection: Augmentin is First-Line

The 2012 IDSA guideline and the 2025 AAO-HNS guideline both recommend amoxicillin-clavulanate (Augmentin) as first-line therapy for ABRS in adults 1, 2, 3. This represents a shift from older recommendations of amoxicillin alone, reflecting increasing β-lactamase-producing bacteria (particularly H. influenzae and M. catarrhalis).

Dosing:

  • Standard dose: 875 mg/125 mg twice daily for 5-7 days in adults 1
  • High-dose (2g twice daily) is reserved for patients with:
    • Recent antibiotic use (within 30 days)
    • High local resistance rates
    • Severe symptoms
    • However, recent trials show high-dose provides no additional benefit over standard-dose and causes more diarrhea 4, 5

Adding Intranasal Corticosteroids: The Synergistic Benefit

The 2012 IDSA guideline specifically recommends intranasal corticosteroids as adjunctive therapy to antibiotics (weak recommendation, moderate evidence) 1. The 2020 European Position Paper on Rhinosinusitis confirms this benefit 6.

Key benefits of adding Flonase:

  • Faster symptom relief: Multiple studies show significantly greater reduction in total symptom scores when intranasal steroids are added to antibiotics versus antibiotics alone 7, 6
  • Improved specific symptoms: Particularly effective for nasal congestion, headache, and facial pain 6
  • Shortened time to clinical success: Studies demonstrate patients achieve symptom resolution 2-3 days faster 6
  • Enhanced in allergic patients: The benefit is most pronounced in patients with concurrent allergic rhinitis 1, 8

The Clinical Algorithm

For confirmed ABRS (symptoms >10 days without improvement, or worsening after initial improvement, or severe onset):

  1. Start Augmentin 875/125 mg twice daily for 5-7 days 1

  2. Add Flonase (fluticasone propionate) 2 sprays per nostril once or twice daily 1, 9

    • Alternative: Any intranasal corticosteroid (mometasone, budesonide) is effective 6, 7
    • Continue for 14-21 days (longer than antibiotic course) 6
  3. Reassess at 72 hours: If no improvement or worsening, consider:

    • Treatment failure (switch antibiotics)
    • Complications (imaging if severe headache, vision changes, periorbital swelling)
    • Alternative diagnosis

Important Caveats

Watchful waiting is an option: The 2025 AAO-HNS guideline now extends watchful waiting (without antibiotics) to all patients with uncomplicated ABRS regardless of severity, not just mild cases 2, 3. This reflects evidence that many cases resolve spontaneously. However, if you choose to treat with antibiotics, adding intranasal steroids is beneficial.

The effect size is modest: While statistically significant, the European guidelines note the effect of intranasal steroids is "small" in absolute terms 6. The benefit is most clinically meaningful in:

  • Patients with allergic rhinitis
  • Those seeking faster symptom relief
  • Recurrent sinusitis patients

Safety profile: Intranasal corticosteroids are well-tolerated with no increased adverse events compared to placebo 6. No HPA axis suppression was observed even at high doses 7.

Pediatric Considerations

For children 3 months to 18 years with ABRS, the combination is also effective 10, 11, 8, 9:

  • Augmentin: 80-90 mg/kg/day divided twice daily for 10-14 days 11
  • Fluticasone: Age-appropriate dosing for 14 days
  • Studies show 96% efficacy when combined in children with concurrent allergic rhinitis versus 88% with antibiotics alone 8

What NOT to Do

Avoid these common errors:

  • Don't use decongestants or antihistamines as adjunctive therapy—they are NOT recommended and provide no benefit 1
  • Don't prescribe fluoroquinolones or macrolides as first-line (reserve for true penicillin allergy) 1, 12, 13
  • Don't treat for >7 days in adults without reassessment 1
  • Don't use intranasal steroids alone without antibiotics for confirmed ABRS (though they work well for post-viral rhinosinusitis) 6

References

Guideline

clinical practice guideline: adult sinusitis update.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2025

Guideline

executive summary of the clinical practice guideline on adult sinusitis update.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2025

Research

Effective dose range of mometasone furoate nasal spray in the treatment of acute rhinosinusitis.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.